These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17941855

  • 1. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW, Yoon JK, An YS, Lee PH.
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [Abstract] [Full Text] [Related]

  • 2. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R.
    Neurology; 2010 Mar 16; 74(11):885-92. PubMed ID: 20181924
    [Abstract] [Full Text] [Related]

  • 3. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
    Brooks DJ.
    Mov Disord; 2009 Mar 16; 24 Suppl 2():S742-7. PubMed ID: 19877240
    [Abstract] [Full Text] [Related]

  • 4. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
    Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT.
    Eur J Nucl Med Mol Imaging; 2005 Oct 16; 32(10):1176-85. PubMed ID: 15931516
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases.
    Brumberg J, Blazhenets G, Bühler S, Fostitsch J, Rijntjes M, Ma Y, Eidelberg D, Weiller C, Jost WH, Frings L, Schröter N, Meyer PT.
    Ann Neurol; 2024 Sep 16; 96(3):539-550. PubMed ID: 38888141
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
    Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T.
    Neurology; 2009 Jul 28; 73(4):273-8. PubMed ID: 19474411
    [Abstract] [Full Text] [Related]

  • 11. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H, Shinotoh H, Hirano S, Miyoshi M, Sato K, Tanaka N, Ota T, Fukushi K, Irie T, Ito H, Higuchi M, Kuwabara S, Suhara T.
    Mov Disord; 2013 Feb 28; 28(2):169-75. PubMed ID: 23225334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia.
    Borroni B, Premi E, Formenti A, Turrone R, Alberici A, Cottini E, Rizzetti C, Gasparotti R, Padovani A.
    Parkinsonism Relat Disord; 2015 Sep 28; 21(9):1049-55. PubMed ID: 26109553
    [Abstract] [Full Text] [Related]

  • 15. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, Kishida H, Ueda N, Nakano T, Takahashi T, Koyano S, Takeuchi H, Tanaka F.
    J Neurol Sci; 2018 Feb 15; 385():99-104. PubMed ID: 29406924
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of univariate and multivariate analyses for brain [18F]FDG PET data in α-synucleinopathies.
    Carli G, Meles SK, Reesink FE, de Jong BM, Pilotto A, Padovani A, Galbiati A, Ferini-Strambi L, Leenders KL, Perani D.
    Neuroimage Clin; 2023 Feb 15; 39():103475. PubMed ID: 37494757
    [Abstract] [Full Text] [Related]

  • 19. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A, Stefanis L, Emmanouilidou E, Vekrelis K, Kapaki E.
    J Neural Transm (Vienna); 2020 Mar 15; 127(3):311-322. PubMed ID: 31912280
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.